CHRIS A. RALLIS - 06 Jul 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Issuer symbol
FENC
Transactions as of
06 Jul 2023
Net transactions value
-$18,624
Form type
4
Filing time
06 Jul 2023, 17:20:41 UTC
Previous filing
13 Jun 2023
Next filing
24 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale $18,693 -2,207 -7.1% $8.47 28,826 06 Jul 2023 Direct F1
transaction FENC Common Shares Options Exercise $5,069 +5,280 +18% $0.9600* 34,106 06 Jul 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise $5,000 -5,208 -2.5% $0.9600* 203,978 06 Jul 2023 Options 5,208 $0.9600 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligation on option exercise.
F2 Shares acquired through the exercise of an option contract with strike price of $0.96 and an expiration date of August 6, 2023.
F3 Represents options granted on August 6, 2013, with a strike price of $0.96 and expiration date of August 6, 2023.